Jacobs Levy Equity Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-45
| Closed | -$49K | – | 1077 |
|
|
2016
Q3 | $49K | Hold |
45
| – | – | ﹤0.01% | 991 |
|
|
2016
Q2 | $34K | Sell |
45
-1
| -2% | -$756 | ﹤0.01% | 1130 |
|
|
2016
Q1 | $32K | Sell |
46
-34
| -43% | -$23.7K | ﹤0.01% | 1075 |
|
|
2015
Q4 | $79K | Buy |
80
+53
| +196% | +$52.3K | ﹤0.01% | 759 |
|
|
2015
Q3 | $29K | Buy |
+27
| New | +$29K | ﹤0.01% | 796 |
|
|
2015
Q1 | – | Sell |
-17
| Closed | -$17K | – | 902 |
|
|
2014
Q4 | $17K | Buy |
+17
| New | +$17K | ﹤0.01% | 805 |
|
|
2014
Q1 | – | Sell |
-27
| Closed | -$61K | – | 1027 |
|
|
2013
Q4 | $61K | Buy |
+27
| New | +$61K | ﹤0.01% | 922 |
|
|
2013
Q3 | – | Sell |
-13
| Closed | -$119K | – | 1039 |
|
|
2013
Q2 | $119K | Buy |
+13
| New | +$119K | ﹤0.01% | 928 |
|